<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diagnosis of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) requires that a patient have both a clinical event (<z:mp ids='MP_0005048'>thrombosis</z:mp> or pregnancy loss) and persistently positive <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> are the most common neurologic manifestations of APS, both <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> and magnetic resonance imaging (MRI) white matter hyperintensities can occur in aPL-positive patients (with or without APS) </plain></SENT>
<SENT sid="2" pm="."><plain>Relatively little is known about the cognitive pattern in aPL-positive patients; MRI white matter hyperintensities may be related to underlying attentional and executive <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Studies with sophisticated neuroimaging techniques aimed to better understand MRI white matter hyperintensities may eventually facilitate our understanding of <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> in aPL-positive patients </plain></SENT>
</text></document>